{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:17:23Z","timestamp":1788959843685,"version":"build-2803163510"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) represents a significant global health burden with limited approved pharmacotherapies. This therapeutic gap necessitates exploration of alternative strategies targeting the underlying inflammatory drivers of disease progression. NAFLD pathogenesis is characterized by chronic dysregulation of the cytokine milieu, promoting the transition from simple steatosis to steatohepatitis and fibrosis. This review critically evaluates mechanistic evidence for specific nutraceuticals\u2014omega-3 fatty acids (EPA\/DHA), vitamins D, E, and B, and curcumin\u2014in modulating these immunometabolic pathways. Accumulating evidence indicates that these agents suppress pro-inflammatory mediators (e.g., IL-6, IL-1\u03b2) and enhance anti-inflammatory signals (e.g., IL-10) through inhibition of central regulators such as NF-\u03baB and the NLRP3 inflammasome. However, their efficacy is context-dependent, with DHA demonstrating relatively consistent anti-fibrotic effects in preclinical models, curcumin exhibiting formulation- and bioavailability-dependent benefits, and EPA and vitamin D showing variable responses across studies and disease stages. Collectively, these findings highlight cytokine-targeted precision nutrition as a promising strategy for NAFLD management and underscore the need for robust clinical trials to establish personalized therapeutic protocols.<\/jats:p>","DOI":"10.3389\/fcell.2026.1745316","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:42:35Z","timestamp":1775022155000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Precision nutrition for NAFLD: a mechanistic rationale for targeting the cytokine landscape"],"prefix":"10.3389","volume":"14","author":[{"given":"Amin","family":"Ullah","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bairong","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e16855","DOI":"10.7759\/cureus.16855","article-title":"The role of vitamins in non-alcoholic fatty liver disease: a systematic review","volume":"13","author":"Abe","year":"2021","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.22038\/IJBMS.2024.75293.16320","article-title":"Curcumin and saroglitazar attenuate diet-induced nonalcoholic steatohepatitis by activating the Nrf2 pathway and suppressing ERK1\/2 signaling","volume":"27","author":"Afarin","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","article-title":"Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-\u03baB translocation","volume":"44","author":"Afrin","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.intimp.2017.05.035","article-title":"Curcumin reduces the risk of chronic kidney damage in mice with nonalcoholic steatohepatitis by modulating endoplasmic reticulum stress and MAPK signaling","volume":"49","author":"Afrin","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1024\/0300-9831\/a000086","article-title":"Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver","volume":"81","author":"Akcam","year":"2011","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12887-024-04993-8","article-title":"Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial","volume":"24","author":"Al-Baiaty","year":"2024","journal-title":"BMC Pediatr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/apt.18149","article-title":"The effect of vitamin E and docosahexaenoic acid ethyl ester on metabolic dysfunction-associated steatotic liver disease (MASLD)\u2014A randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD)","volume":"60","author":"Alkhouri","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/13813455.2021.1878539","article-title":"Folic acid ameliorates palmitate-induced inflammation through decreasing homocysteine and inhibiting NF-\u03baB pathway in HepG2 cells","volume":"129","author":"Bagherieh","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/gutjnl-2014-307024","article-title":"Vitamin D counteracts fibrogenic TGF-\u03b2 signalling in human hepatic stellate cells both receptor-dependently and independently","volume":"64","author":"Beilfuss","year":"2015","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00394-011-0254-8","article-title":"Dietary supplementation of herring roe and milt enhances hepatic fatty acid catabolism in female mice transgenic for hTNF\u03b1","volume":"51","author":"Bj\u00f8rndal","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1017\/S0029665112000067","article-title":"Fatty acids: long-chain fatty acids and inflammation","volume":"71","author":"Calder","year":"2012","journal-title":"Proc. Nutr. Soc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/nu12010009","article-title":"Protective effect of \u03b1-Linolenic acid on non-alcoholic hepatic steatosis and Interleukin-6 and -10 in wistar rats","volume":"12","author":"Candido","year":"2020","journal-title":"Nutrients"},{"key":"B13","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1017\/S0007114507666410","article-title":"Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver","volume":"97","author":"Chang","year":"2007","journal-title":"Br. J. Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"109920","DOI":"10.1016\/j.jnutbio.2025.109920","article-title":"Curcumin mitigates obesity-driven dysbiosis and liver steatosis while promoting browning and thermogenesis in white adipose tissue of high-fat diet-fed mice","volume":"143","author":"Chiu","year":"2025","journal-title":"J. Nutr. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3349\/ymj.2024.0038","article-title":"Vitamin D attenuates non-alcoholic fatty liver disease in high-fat diet-induced obesity murine model","volume":"66","author":"Chung","year":"2025","journal-title":"Yonsei Med. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e13789","DOI":"10.14814\/phy2.13789","article-title":"Curcumin supplementation mitigates NASH development and progression in female wistar rats","volume":"6","author":"Cunningham","year":"2018","journal-title":"Physiol. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/bab.2666","article-title":"Combined effects of vitamin D3 and dioxopiperidinamide derivative on lipid homeostasis, inflammatory pathways, and redox imbalance in non-alcoholic fatty liver disease in vivo zebrafish model","volume":"72","author":"Dharshan","year":"2025","journal-title":"Biotechnol. Appl. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.30937","article-title":"Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice","volume":"71","author":"Dong","year":"2020","journal-title":"Hepatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12876-017-0688-4","article-title":"Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift","volume":"17","author":"Drori","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbalip.2012.10.002","article-title":"Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity","volume":"1831","author":"Du","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Cell. Biol. Lipids"},{"key":"B22","doi-asserted-by":"publisher","first-page":"880298","DOI":"10.3389\/fimmu.2022.880298","article-title":"Association of inflammatory cytokines with non-alcoholic fatty liver disease","volume":"13","author":"Duan","year":"2022","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cbi.2018.04.010","article-title":"Vitamin D nanoemulsion enhances hepatoprotective effect of conventional vitamin D in rats fed with a high-fat diet","volume":"288","author":"El-Sherbiny","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34309","DOI":"10.1038\/s41598-025-11135-2","article-title":"Curcumin\u2019s dual effect on pyroptosis and autophagy in metabolic-associated fatty liver disease: a potential therapeutic strategy","volume":"15","author":"Eldken","year":"2025","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"11705","DOI":"10.1039\/d2fo02349k","article-title":"Elevated serum phosphatidylcholine (16:1\/22:6) levels promoted by fish oil and vitamin D3 are highly correlated with biomarkers of non-alcoholic fatty liver disease in Chinese subjects","volume":"158","author":"Fan","year":"2022","journal-title":"Food Funct."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8742075","DOI":"10.1155\/2019\/8742075","article-title":"Evaluation of the effect derived from silybin with vitamin D and vitamin E administration on clinical, metabolic, endothelial dysfunction, oxidative stress parameters, and serological worsening markers in nonalcoholic fatty liver disease patients","volume":"2019","author":"Federico","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12967-022-03579-1","article-title":"A new nutraceutical (livogen plus\u00ae) improves liver steatosis in adults with non-alcoholic fatty liver disease","volume":"20","author":"Ferro","year":"2022","journal-title":"J. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.26355\/eurrev_202112_27442","article-title":"A randomized controlled trial comparing the effects of vitamin E, ursodeoxycholic acid and pentoxifylline on Egyptian non-alcoholic steatohepatitis patients","volume":"25","author":"Fouda","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3181\/0707-RM-207","article-title":"Evidence-based efficacy of kampo formulas in a model of non alcoholic fatty liver","volume":"233","author":"Fujimoto","year":"2008","journal-title":"Exp. Biol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1152\/ajpgi.00181.2013","article-title":"Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease","volume":"306","author":"Ganji","year":"2014","journal-title":"Am. J. Physiol. - Gastrointest. Liver Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.metabol.2015.05.002","article-title":"Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: impact on non-alcoholic fatty liver disease","volume":"64","author":"Ganji","year":"2015","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","first-page":"104909","DOI":"10.1016\/j.jbc.2023.104909","article-title":"Mitochondrial folate metabolism\u2013mediated \u03b1-linolenic acid exhaustion masks liver fibrosis resolution","volume":"299","author":"Gao","year":"2023","journal-title":"J. Biol. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/ejvs.2025.342023.2546","article-title":"The protective effect of curcumin and niacin against non-alcoholic fatty liver disease in high fat high fructose fed sprague-dawley rats","author":"Ghandour","year":"2025","journal-title":"Egypt J. Vet. Sci. 0"},{"key":"B34","volume-title":"Metabolic dysfunction-associated steatotic liver disease (M\u0391SLD)","author":"Girish","year":"2025"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00394-021-02772-0","article-title":"The effects of fish oil plus vitamin D3 intervention on non-alcoholic fatty liver disease: a randomized controlled trial","volume":"61","author":"Guo","year":"2022","journal-title":"Eur. J. Nutr."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1336493","DOI":"10.3389\/fimmu.2024.1336493","article-title":"Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4093\/dmj.2022.0110","article-title":"Beneficial effects of a curcumin derivative and transforming growth Factor-\u03b2 receptor I inhibitor combination on nonalcoholic steatohepatitis","volume":"47","author":"Ha","year":"2023","journal-title":"Diabetes Metab. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7812\/TPP\/21.204","article-title":"B vitamins: functions and uses in medicine","volume":"26","author":"Hanna","year":"2022","journal-title":"Perm. J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.numecd.2019.12.007","article-title":"Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice","volume":"30","author":"Harari","year":"2020","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor-\u03b21 level and efficacy of \u03b1-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1227046","DOI":"10.3389\/fmed.2023.1227046","article-title":"NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials","volume":"10","author":"Hegazi","year":"2023","journal-title":"Front. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jcpt.12784","article-title":"The effect of Alpha-linolenic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"44","author":"Hosseinpour-Arjmand","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e14032","DOI":"10.14814\/phy2.14032","article-title":"The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats","volume":"7","author":"Ibrahim","year":"2019","journal-title":"Physiol. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10735-023-10118-9","article-title":"1,25-Dihydroxycholecalciferol down-regulates 3-mercaptopyruvate sulfur transferase and caspase-3 in rat model of non-alcoholic fatty liver disease","volume":"54","author":"Ibrahim","year":"2023","journal-title":"J. Mol. Histol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/carcin\/bgx112","article-title":"Eicosapentaenoic acid attenuates obesity-related hepatocellular carcinogenesis","volume":"39","author":"Inoue-Yamauchi","year":"2018","journal-title":"Carcinogenesis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e100627","DOI":"10.1371\/journal.pone.0100627","article-title":"L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway","volume":"9","author":"Ishikawa","year":"2014","journal-title":"PLoS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3390\/nu13124440","article-title":"Curcumin in metabolic health and disease","volume":"13","author":"Jabczyk","year":"2021","journal-title":"Nutrients"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9333","DOI":"10.12998\/wjcc.v9.i31.9333","article-title":"Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: omega-3 long-chain polyunsaturated fatty acids","volume":"9","author":"Jeyakumar","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2014.12.003","article-title":"Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis","volume":"96","author":"Kabel","year":"2015","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10620-010-1400-5","article-title":"Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet","volume":"56","author":"Kajikawa","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"dmm048355","DOI":"10.1242\/DMM.048355","article-title":"High-dose vitamin B1 therapy prevents the development of experimental fatty liver driven by overnutrition","volume":"14","author":"Kalyesubula","year":"2021","journal-title":"DMM Dis. Model. Mech."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3748\/WJG.V26.I17.1993","article-title":"Metabolic inflammation as an instigator of fibrosis during nonalcoholic fatty liver disease","volume":"26","author":"Katsarou","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.23736\/S0026-4806.18.05845-7","article-title":"Beneficial effects of probiotic combination with omega fatty acids in NAFLD: a randomized clinical study","volume":"109","author":"Kobyliak","year":"2018","journal-title":"Minerva Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3892\/ijmm.2012.1049","article-title":"Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis","volume":"30","author":"Kuo","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.26390","article-title":"Vitamin D and NAFLD: is it more than just an association?","volume":"58","author":"Kwok","year":"2013","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3390\/cimb44010029","article-title":"Validation of a quantification method for curcumin derivatives and their hepatoprotective effects on nonalcoholic fatty liver disease","volume":"44","author":"Lee","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1598588","DOI":"10.3389\/fnut.2025.1598588","article-title":"Omega-3 fatty acids: multi-target mechanisms and therapeutic applications in neurodevelopmental disorders and epilepsy","volume":"12","author":"Li","year":"2025","journal-title":"Front. Nutr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41538-025-00466-z","article-title":"Curcumin alleviates visceral adiposity via inhibiting GIP release from hypoxic intestinal damage in MASH rats","volume":"9","author":"Liao","year":"2025","journal-title":"Npj Sci. Food"},{"key":"B59","doi-asserted-by":"publisher","first-page":"310981","DOI":"10.1155\/2014\/310981","article-title":"Enhanced amelioration of high-fat diet-induced fatty liver by docosahexaenoic acid and lysine supplementations","volume":"2014","author":"Lin","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"117086","DOI":"10.1016\/j.lfs.2019.117086","article-title":"Active vitamin D supplementation alleviates initiation and progression of nonalcoholic fatty liver disease by repressing the p53 pathway","volume":"241","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1528768","DOI":"10.3389\/fendo.2025.1528768","article-title":"1,25-dihydroxyvitamin D3 improves non-alcoholic steatohepatitis phenotype in a diet-induced rat model","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin e in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.1038\/s41598-023-33023-3","article-title":"An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand","volume":"13","author":"Lukkunaprasit","year":"2023","journal-title":"Sci. Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.4251\/WJGO.V16.I12.4685","article-title":"Vitamin D 1, 25-Dihydroxyvitamin D3 reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization","volume":"16","author":"Luo","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1194\/jlr.M061275","article-title":"Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-\/- mice by targeting the TGF\u03b2-Smad3 pathway","volume":"56","author":"Lytle","year":"2015","journal-title":"J. Lipid Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0173376","DOI":"10.1371\/journal.pone.0173376","article-title":"Docosahexaenoic acid blocks progression of Western diet-induced nonalcoholic steatohepatitis in obese Ldlr-\/- mice","volume":"12","author":"Lytle","year":"2017","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1007\/s10620-019-05560-3","article-title":"Antifibrotic effects of 1,25(OH)2D3 on nonalcoholic steatohepatitis in female mice","volume":"64","author":"Ma","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.7554\/eLife.109214","article-title":"NAD + boosting by oral nicotinamide mononucleotide administration regulates key metabolic and immune pathways through SIRT1 dependent and independent mechanisms to mitigate diet-induced obesity and dyslipidemia in mice","author":"Majeed","year":"2025","journal-title":"Elife, bioRxiv"},{"key":"B70","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1440-1746.2010.06326.x","article-title":"Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by 1H-magnetic resonance spectroscopy in a rat model","volume":"26","author":"Marsman","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"C Gastroenterol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ejphar.2017.10.048","article-title":"Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH\/NADP+ and GSH\/GSSG ratios and reducing oxidative and inflammatory stress","volume":"818","author":"Mej\u00eda","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00394-024-03554-0","article-title":"Vitamin D supplementation alleviates high fat diet-induced metabolic associated fatty liver disease by inhibiting ferroptosis pathway","volume":"64","author":"Miao","year":"2025","journal-title":"Eur. J. Nutr."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.dld.2020.09.021","article-title":"Antioxidant activity of hydroxytyrosol and vitamin E reduces systemic inflammation in children with paediatric NAFLD","volume":"53","author":"Mosca","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejphar.2017.11.046","article-title":"DHA supplementation prevent the progression of NASH via GPR120 signaling","volume":"820","author":"Nakamoto","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e88005","DOI":"10.1371\/journal.pone.0088005","article-title":"Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease","volume":"9","author":"Nobili","year":"2014","journal-title":"PLoS One"},{"key":"B78","doi-asserted-by":"publisher","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: a clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/nu14183791","article-title":"Combination treatment with hydroxytyrosol and vitamin E improves NAFLD-related fibrosis","volume":"14","author":"Panera","year":"2022","journal-title":"Nutrients"},{"key":"B80","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13104-019-4540-5","article-title":"Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis","volume":"12","author":"Pickich","year":"2019","journal-title":"BMC Res. Notes"},{"key":"B81","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/liv.12122","article-title":"1,25-dihydroxyvitamin D3 and its nuclear receptor repress human \u03b11(I) collagen expression and type I collagen formation","volume":"33","author":"Potter","year":"2013","journal-title":"Liver Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/liv.12500","article-title":"N-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis","volume":"34","author":"Provenzano","year":"2014","journal-title":"Liver Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e0133496","DOI":"10.1371\/journal.pone.0133496","article-title":"Fish oil supplements lower serum lipids and glucose in correlation with a reduction in plasma fibroblast growth factor 21 and prostaglandin E2 in nonalcoholic fatty liver disease associated with hyperlipidemia: a randomized clinical trial","volume":"10","author":"Qin","year":"2015","journal-title":"PLoS One"},{"key":"B84","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.3390\/molecules28135032","article-title":"Specialized pro-resolving lipid mediators: endogenous roles and pharmacological activities in infections","volume":"28","author":"Rasquel-Oliveira","year":"2023","journal-title":"Molecules"},{"key":"B85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12876-019-1055-4","article-title":"Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial","volume":"19","author":"Saadati","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"102322","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1163950","DOI":"10.3389\/fnut.2023.1163950","article-title":"The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers","volume":"10","author":"Safari","year":"2023","journal-title":"Front. Nutr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jgh3.12010","article-title":"Vitamin D supplementation in patients with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"1","author":"Sakpal","year":"2017","journal-title":"JGH Open"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e70606","DOI":"10.1111\/jcmm.70606","article-title":"Innovative approaches to NAFLD: exploring the role of nicotinamide in multicellular microtissue models of liver fibrosis","volume":"29","author":"Sani","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12020-014-0336-5","article-title":"Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial","volume":"47","author":"Sharifi","year":"2014","journal-title":"Endocrine"},{"key":"B91","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/lipd.12084","article-title":"Folic acid supplementation attenuates chronic hepatic inflammation in high-fat diet fed mice","volume":"53","author":"Sid","year":"2018","journal-title":"Lipids"},{"key":"B92","doi-asserted-by":"publisher","first-page":"7716","DOI":"10.1038\/s41598-022-11950-x","article-title":"Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis","volume":"12","author":"Sindhughosa","year":"2022","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"17226","DOI":"10.3390\/ijms242417226","article-title":"The ameliorating effects of n-3 polyunsaturated fatty acids on liver steatosis induced by a high-fat methionine choline-deficient diet in mice","volume":"24","author":"\u0160m\u00edd","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"101939","DOI":"10.1016\/j.xcrm.2025.101939","article-title":"Vitamin E (300 mg) in the treatment of MASH: a multi-center, randomized, double-blind, placebo-controlled study","volume":"6","author":"Song","year":"2025","journal-title":"Cell. Rep. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"e31151","DOI":"10.1002\/jcp.31151","article-title":"Apoptosis antagonizing transcription factor-mediated liver damage and inflammation to cancer: therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis-hepatocellular carcinoma","volume":"239","author":"Srinivas","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0194867","DOI":"10.1371\/journal.pone.0194867","article-title":"Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal\/adipose tissue alteration in a diet-induced steatohepatitis rat model","volume":"13","author":"Su","year":"2018","journal-title":"PLoS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.3748\/wjg.v22.i8.2533","article-title":"Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation","volume":"22","author":"Sui","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J. Clin. Gastroenterol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1177\/09603271211038741","article-title":"Effect of curcumin on the non-alcoholic steatohepatitis via inhibiting the M1 polarization of macrophages","volume":"40","author":"Tong","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jhep.2013.03.024","article-title":"Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease","volume":"59","author":"Tr\u00e9po","year":"2013","journal-title":"J. Hepatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"111730","DOI":"10.1016\/j.mce.2022.111730","article-title":"CXCL13 and CXCR5 are upregulated in PCOS mice ovaries but downregulated following metformin administration","volume":"556","author":"Ullah","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s11154-023-09800-w","article-title":"A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: type 2 diabetes and nonalcoholic fatty liver disease","volume":"4","author":"Ullah","year":"","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2023.1272536","article-title":"Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus","volume":"11","author":"Ullah","year":"","journal-title":"Front. Cell. Dev. Biol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"107213","DOI":"10.1016\/j.phrs.2024.107213","article-title":"Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: insights from preclinical and clinical studies\u2019 outcomes","volume":"204","author":"Ullah","year":"","journal-title":"Pharmacol. Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s11658-024-00591-9","article-title":"The role of proinflammatory cytokines and CXC chemokines (CXCL1\u2013CXCL16) in the progression of prostate cancer: insights on their therapeutic management","volume":"29","author":"Ullah","year":"","journal-title":"Cell. Mol. Biol. Lett."},{"key":"B106","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s11154-024-09884-y","article-title":"Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases)","volume":"25","author":"Ullah","year":"","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B107","doi-asserted-by":"publisher","first-page":"122277","DOI":"10.1016\/j.lfs.2023.122277","article-title":"Involvement of CXC chemokines (CXCL1-CXCL17) in gastric cancer: prognosis and therapeutic molecules","volume":"336","author":"Ullah","year":"","journal-title":"Life Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1039\/c5fo01086a","article-title":"Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Food Funct."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/nu17101657","article-title":"Nutraceutical strategies for metabolic dysfunction-associated steatotic liver disease (MASLD): a path to liver health","volume":"17","author":"Vrentzos","year":"2025","journal-title":"Nutrients"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1111\/bph.13844","article-title":"Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease","volume":"174","author":"Wang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.biopha.2018.11.088","article-title":"A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease","volume":"110","author":"Wu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/nu17121972","article-title":"Curcumin for inflammation control in individuals with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial","volume":"17","author":"Yaikwawong","year":"2025","journal-title":"Nutrients"},{"key":"B113","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.abb.2020.108486","article-title":"Eicosapentaenoic acid-containing polar lipids from seaweed susabinori (Pyropia yezoensis) alleviate hepatic steatosis in obese db\/db mice","volume":"691","author":"Yanagita","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1684\/ecn.2019.0437","article-title":"Effect of folate supplementation on immunological and autophagy markers in experimental nonalcoholic fatty liver disease","volume":"30","author":"Youssry","year":"2019","journal-title":"Eur. Cytokine Netw."},{"key":"B116","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/ph18050650","article-title":"A comparative study of N-Acetyl cysteine, rosuvastatin, and vitamin E in the management of patients with non-alcoholic steatohepatitis: a randomized controlled trial","volume":"18","author":"Zakaria","year":"2025","journal-title":"Pharmaceuticals"},{"key":"B117","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12325-018-0670-8","article-title":"Haptoglobin genotype and vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis in China: a multicenter, randomized, placebo-controlled trial design","volume":"35","author":"Zang","year":"2018","journal-title":"Adv. Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1039\/d0fo03471a","article-title":"DHA-enriched phosphatidylserine ameliorates non-alcoholic fatty liver disease and intestinal dysbacteriosis in mice induced by a high-fat diet","volume":"12","author":"Zhou","year":"2021","journal-title":"Food Funct."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1745316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:42:37Z","timestamp":1775022157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1745316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":118,"alternative-id":["10.3389\/fcell.2026.1745316"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1745316","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1745316"}}